Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India
Open Access
- 8 August 2015
- journal article
- research article
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 47 (4) , 331-335
Abstract
The validity of self-reported tobacco use is often questioned given the potential for underestimation of use. This study used data from a double-blind, placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India to evaluate the accuracy of self-reported smokeless tobacco cessation using biochemical validation procedures and to evaluate correlates of reporting inaccuracy. Smokeless tobacco users attending a dental clinic at AIIMS were randomized to placebo or varenicline; all participants received counseling. Detailed smokeless tobacco use was recorded and abstinence was defined as cotinine-verified 7-day point prevalence cessation (cotinine < 50 ng/ml) and breath CO > 10 ppm at the end of 12 weeks of treatment. One-half of study completers (82/165) self-reported abstinence. Biochemical verification confirmed that (65.9%) subjects provided accurate self-reports while (34.1%) participants underreported tobacco use. These data indicate poor agreement between self-reported and biochemically confirmed abstinence (κ = −0.191). Underreporters of tobacco use had significantly higher baseline cotinine (p < 0.05), total craving (p < 0.012), and negative reinforcement craving (p < 0.001) vs. those whose self-reports were correctly verified. These findings provide evidence to support the need for biochemical validation of self-reported abstinence outcomes among smokeless tobacco users in cessation programs in India and identify high levels of pretreatment cotinine and craving levels as potential correlates of false reporting.Keywords
Funding Information
- National Institute on Drug Abuse (R21 DA026404, R01 DA025078)
- National Cancer Institute (P30 CA916520)
- National Institute on Drug Abuse, the National Cancer Institute, the National Institute of General Medical Sciences, and the National Human Genome Research Institute (U01 DA020830)
- National Institute on Drug Abuse and National Cancer Institute (P50 CA143187)
This publication has 24 references indexed in Scilit:
- Concordance between Urinary Cotinine Levels and Self-Reported Tobacco Use among Drug-Dependent Persons: A Pilot StudySubstance Abuse, 2012
- Time to First Cigarette after Waking Predicts Cotinine LevelsCancer Epidemiology, Biomarkers & Prevention, 2009
- Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependenceNicotine & Tobacco Research, 2007
- Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: A preliminary studyDrug and Alcohol Dependence, 2007
- Can We Trust National Smoking Prevalence Figures? Discrepancies Between Biochemically Assessed and Self-Reported Smoking Rates in Three CountriesCancer Epidemiology, Biomarkers & Prevention, 2007
- The accuracy of self-reported smoking status assessed by cotinine test stripsNicotine & Tobacco Research, 2002
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Individual differences in the subjective effects of the first cigarette of the day: A self-report method for studying tolerance.Experimental and Clinical Psychopharmacology, 1997
- Individual differences in the subjective effects of the first cigarette of the day: A self-report method for studying tolerance.Experimental and Clinical Psychopharmacology, 1997
- Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality and Social Psychology, 1988